On ECHEMI
Home > Drugs > Guangdong Jianxin Pharmaceutical Co., Ltd.
Guangdong Jianxin Pharmaceutical Co., Ltd.
  • Founded in:

    2006-11-02
  • Country:

    China China
  • Address:

    Jianxin Pharmaceutical Industrial Park, Zhupu District, Sanlian Industrial Zone, Haojiang District, Shantou City
  • Tax NO.:

    91440512794663657G
  • Registered Funds:

    60 million yuan
  • Website:

  • Email:

Related Drugs
Propyl Gallate for Injection
The main ingredient of this product is propyl gallate
Name Description Content CAS NO. Registered Holders
Propyl gallate

1. It can obviously inhibit the synthesis of thromboxane A2 (TXA2), counteract the platelet aggregation caused by arachidonic acid (AA), and has a stronger and faster antiplatelet aggregation effect than aspirin (ASP). 2. It can enhance the fibrinolytic activity and promote the dissolution of thrombus. 3. It can reduce the specific viscosity of whole blood and plasma, and accelerate the electrophoresis of red blood cells. 4. It can relax the vascular smooth muscle, dilate the artery, and increase the blood flow of the coronary artery and cerebral artery. 5. It can improve the ability to resist hypoxia. 6. It can strongly scavenge free radicals. 7. It can inhibit the inflammatory exudation of capillaries.

More

1. It can obviously inhibit the synthesis of thromboxane A2 (TXA2), counteract the platelet aggregation caused by arachidonic acid (AA), and has a stronger and faster antiplatelet aggregation effect than aspirin (ASP). 2. It can enhance the fibrinolytic activity and promote the dissolution of thrombus. 3. It can reduce the specific viscosity of whole blood and plasma, and accelerate the electrophoresis of red blood cells. 4. It can relax the vascular smooth muscle, dilate the artery, and increase the blood flow of the coronary artery and cerebral artery. 5. It can improve the ability to resist hypoxia. 6. It can strongly scavenge free radicals. 7. It can inhibit the inflammatory exudation of capillaries.

121-79-9 10
Urokinase for injection
This product is an enzyme protein separated from healthy human urine or obtained from human kidney tissue culture. It consists of two parts with molecular weights of 33,000 (LMW-tcu-PA) and 54,000 (HMW-tcu-PA).
Name Description Content CAS NO. Registered Holders
Enzyme protein isolated from healthy human urine (LMW-tcu-PA)

It acts directly on the endogenous fibrinolytic system, catalyzing the cleavage of plasminogen into plasmin, degrading fibrin clots, fibrinogen in the blood circulation, coagulation factor V and coagulation factor VIII, etc.; it increases the activity of vascular ADPase, inhibits ADP-induced platelet aggregation; it shows that the thrombolytic effect is significantly related to the drug dosage and the time window of administration; it may increase the risk of severe bleeding.

More

It acts directly on the endogenous fibrinolytic system, catalyzing the cleavage of plasminogen into plasmin, degrading fibrin clots, fibrinogen in the blood circulation, coagulation factor V and coagulation factor VIII, etc.; it increases the activity of vascular ADPase, inhibits ADP-induced platelet aggregation; it shows that the thrombolytic effect is significantly related to the drug dosage and the time window of administration; it may increase the risk of severe bleeding.

0
Enzyme protein obtained from human kidney tissue culture (HMW-tcu-PA)

It acts directly on the endogenous fibrinolytic system, catalyzing the cleavage of plasminogen into plasmin, degrading fibrin clots, fibrinogen in the blood circulation, coagulation factor V and coagulation factor VIII, etc.; it increases the activity of vascular ADPase, inhibits ADP-induced platelet aggregation; it shows that the thrombolytic effect is significantly related to the drug dosage and the time window of administration; it may increase the risk of severe bleeding.

More

It acts directly on the endogenous fibrinolytic system, catalyzing the cleavage of plasminogen into plasmin, degrading fibrin clots, fibrinogen in the blood circulation, coagulation factor V and coagulation factor VIII, etc.; it increases the activity of vascular ADPase, inhibits ADP-induced platelet aggregation; it shows that the thrombolytic effect is significantly related to the drug dosage and the time window of administration; it may increase the risk of severe bleeding.

0
Cyclic Adenosine Monophosphate for Injection
Cyclic adenosine monophosphate.
Name Description Content CAS NO. Registered Holders
Cyclic AMP

It is a protein kinase activator and a derivative of nucleotides. It is an important substance with physiological activity that is widely present in the human body. It is produced by adenosine triphosphate under the catalysis of adenylate cyclase and can regulate various functional activities of cells. As the second messenger of hormones, it plays a role in regulating physiological functions and material metabolism in cells, can change the function of cell membranes, promote calcium ions in reticulum to enter muscle fibers, thereby enhancing myocardial contraction, and can promote the activity of respiratory chain oxidases, improve myocardial hypoxia, relieve symptoms of coronary heart disease and improve electrocardiograms. In addition, it plays an important role in regulating sugar, fat metabolism, nucleic acid, and protein synthesis.

More

It is a protein kinase activator and a derivative of nucleotides. It is an important substance with physiological activity that is widely present in the human body. It is produced by adenosine triphosphate under the catalysis of adenylate cyclase and can regulate various functional activities of cells. As the second messenger of hormones, it plays a role in regulating physiological functions and material metabolism in cells, can change the function of cell membranes, promote calcium ions in reticulum to enter muscle fibers, thereby enhancing myocardial contraction, and can promote the activity of respiratory chain oxidases, improve myocardial hypoxia, relieve symptoms of coronary heart disease and improve electrocardiograms. In addition, it plays an important role in regulating sugar, fat metabolism, nucleic acid, and protein synthesis.

60-92-4 12
Doxycycline Hydrochloride for Injection
Chemical name: 6-methyl-4-(dimethylamino)-3,5,10,12,12α,-pentahydroxy-1,11-dioxo-1,4,4α,5,5α,6,11,12α-octahydro-2-naphthacenecarboxamide hydrochloride hemiethanol hemihydrate.
Name Description Content CAS NO. Registered Holders
6-Methyl-4-(dimethylamino)-3,5,10,12,12α,-pentahydroxy-1,11-dioxo-1,4,4α,5,5α,6,11,12α-octahydro-2-naphthacenecarboxamide hydrochloride hemiethanol hemihydrate

Tetracycline antibiotics. This product is a broad-spectrum antibacterial agent with bactericidal effects at high concentrations. Rickettsia, Mycoplasma, Chlamydia, atypical mycobacteria, and spirochetes are also sensitive to this product. This product is more effective against Gram-positive bacteria than Gram-negative bacteria, but Enterococcus is resistant to it. Others such as Actinomycetes, Bacillus anthracis, Listeria monocytogenes, Clostridium, Nocardia, Vibrio, Brucella, Campylobacter, and Yersinia are sensitive to this product. This product has certain antibacterial activity against Neisseria gonorrhoeae, but penicillin-resistant Neisseria gonorrhoeae is also resistant to doxycycline. Due to the widespread use of tetracyclines over the years, common clinical pathogens have become seriously resistant to this product, including Gram-positive bacteria such as Staphylococcus and most Gram-negative bacilli. This product is different from tetracycline

More

Tetracycline antibiotics. This product is a broad-spectrum antibacterial agent with bactericidal effects at high concentrations. Rickettsia, Mycoplasma, Chlamydia, atypical mycobacteria, and spirochetes are also sensitive to this product. This product is more effective against Gram-positive bacteria than Gram-negative bacteria, but Enterococcus is resistant to it. Others such as Actinomycetes, Bacillus anthracis, Listeria monocytogenes, Clostridium, Nocardia, Vibrio, Brucella, Campylobacter, and Yersinia are sensitive to this product. This product has certain antibacterial activity against Neisseria gonorrhoeae, but penicillin-resistant Neisseria gonorrhoeae is also resistant to doxycycline. Due to the widespread use of tetracyclines over the years, common clinical pathogens have become seriously resistant to this product, including Gram-positive bacteria such as Staphylococcus and most Gram-negative bacilli. This product is different from tetracycline

0
Sodium norcantharidate for injection
Main ingredients: The main active ingredient is sodium norcantharidin.
Name Description Content CAS NO. Registered Holders
SodiuM DeMethylcantharidate

In vitro tests have destructive or inhibitory effects on the morphology or proliferation of cell lines such as liver cancer, esophageal cancer, laryngeal cancer, lung cancer, and cervical cancer; in vivo tests have a certain inhibitory effect on Ehrlich ascites carcinoma, sarcoma-180 and solid liver cancer in mice, and can increase the respiratory control rate and lysosomal enzyme activity of mitochondria in ascites liver cancer H22 mice, interfere with cancer cell division, block it in the M phase, and affect its cycle speed; destroy the cancer cell skeleton (microfilaments, microtubules), affect the ultrastructure of cancer cells, and cause damage to mitochondria, microvilli and plasma membranes; can inhibit cancer cell DNA synthesis, but has no inhibitory effect on normal bone marrow cells, and can increase white blood cells.

More

In vitro tests have destructive or inhibitory effects on the morphology or proliferation of cell lines such as liver cancer, esophageal cancer, laryngeal cancer, lung cancer, and cervical cancer; in vivo tests have a certain inhibitory effect on Ehrlich ascites carcinoma, sarcoma-180 and solid liver cancer in mice, and can increase the respiratory control rate and lysosomal enzyme activity of mitochondria in ascites liver cancer H22 mice, interfere with cancer cell division, block it in the M phase, and affect its cycle speed; destroy the cancer cell skeleton (microfilaments, microtubules), affect the ultrastructure of cancer cells, and cause damage to mitochondria, microvilli and plasma membranes; can inhibit cancer cell DNA synthesis, but has no inhibitory effect on normal bone marrow cells, and can increase white blood cells.

13114-29-9 0
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.